{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:01:28Z","timestamp":1780038088125,"version":"3.53.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to evaluate the safety and efficacy of transcatheter embolization (TCE) for pulmonary arteriovenous fistula (PAVF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      From January 1, 2003 to December 31, 2024, 28 patients (13 male, 15 female) with 41 PAVFs underwent TCE. Changes in arterial oxygen saturation (SaO\n                      <jats:sub>2<\/jats:sub>\n                      ), procedural success rate, reperfusion rate, and complications were evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The procedural success rate was 100%, with an immediate complete occlusion rate of 87.8%.Postoperative SaO2 was significantly higher than that before operation (92.0% vs. 84.1%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). The 41 PAVFs were divided into four groups (coil group [\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096], MemoPart PDA occluder group [\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200922], ADO II group [\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097], and AVP I group [\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096]). The average diameter of the arteries was 3.17\u2009\u00b1\u20090.7\u2005mm, 11.86\u2009\u00b1\u20093.31\u2005mm, 5.98\u2009\u00b1\u20092.54\u2005mm, and 8.72\u2009\u00b1\u20093.78\u2005mm, respectively, showing a statistically significant difference between groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). The average clinical follow-up time was 19.46\u2009\u00b1\u200926.04 months (range: 6\u2013162 months). During the follow-up period, 2 patients (7.14%) developed fever and 1 patient (3.57%) developed pleural effusion. 1 case (14.29%) of PAVFs experienced reperfusion in the ADO II group, while reperfusion did not occur in the other three groups, and the difference was not statistically significant (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.463).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The adaptable utilization of various occluders can enhance the success rate of achieving effective occlusion. TCE for PAVFs demonstrates high safety and efficacy, with excellent procedural success rates and sustained long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1732994","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:01:45Z","timestamp":1780034505000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of transcatheter embolization for pulmonary arteriovenous fistula: a 21-year retrospective study"],"prefix":"10.3389","volume":"13","author":[{"given":"Hong","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Congenital Heart Disease, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Congenital Heart Disease, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Congenital Heart Disease, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Congenital Heart Disease, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Congenital Heart Disease, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benshen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Congenital Heart Disease, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Congenital Heart Disease, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Congenital Heart Disease, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.0954-6820.1985.tb08832.x","article-title":"Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia","volume":"218","author":"Vase","year":"1985","journal-title":"Acta Med Scand"},{"key":"B2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1067\/j.cpradiol.2017.09.006","article-title":"Persistent pulmonary arteriovenous malformations: percutaneous embolotherapy","volume":"47","author":"Aal","year":"2018","journal-title":"Curr Probl Diagn Radiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10554-018-1479-x","article-title":"Pulmonary arteriovenous malformations","volume":"35","author":"Tellapuri","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-024-00585-z","article-title":"Hereditary haemorrhagic telangiectasia","volume":"11","author":"Hermann","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1148\/rg.210076","article-title":"Ct appearance of pulmonary arteriovenous malformations and mimics","volume":"42","author":"Raptis","year":"2022","journal-title":"Radiographics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3348\/kjr.2021.0417","article-title":"Pulmonary arteriovenous malformation and its vascular mimickers","volume":"23","author":"Lee","year":"2022","journal-title":"Korean J Radiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1055\/s-0033-1359736","article-title":"Management of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia patients","volume":"30","author":"Narsinh","year":"2013","journal-title":"Semin Intervent Radiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00270-019-02396-2","article-title":"Cirse standards of practice on diagnosis and treatment of pulmonary arteriovenous malformations","volume":"43","author":"M\u00fcller-H\u00fclsbeck","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jvir.2024.06.027","article-title":"Vascular plugs improve pulmonary arteriovenous malformation occlusion over coil embolization alone: a proof-of-concept study using dual-energy ct","volume":"35","author":"Yu","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.acra.2022.08.012","article-title":"Diagnosis and management of persistent pulmonary arterio-venous malformations following embolotherapy","volume":"30","author":"Kulkarni","year":"2023","journal-title":"Acad Radiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1449496","DOI":"10.3389\/fmed.2024.1449496","article-title":"Neurological and cardiopulmonary manifestations of pulmonary arteriovenous malformations","volume":"11","author":"Lu","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0003-4975(93)91156-h","article-title":"Pulmonary arteriovenous malformations: therapeutic options","volume":"56","author":"Puskas","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/thoraxjnl-2017-210764","article-title":"British Thoracic society clinical statement on pulmonary arteriovenous malformations","volume":"72","author":"Shovlin","year":"2017","journal-title":"Thorax"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jvir.2025.03.011","article-title":"Transarterial embolization for pulmonary arteriovenous malformation: a systematic review and meta-analysis","volume":"36","author":"Yu","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/thx.2007.087452","article-title":"Primary determinants of ischaemic stroke\/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia","volume":"63","author":"Shovlin","year":"2008","journal-title":"Thorax"},{"key":"B16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan","year":"2011","journal-title":"J Med Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1053\/j.tvir.2008.03.007","article-title":"Pulmonary arteriovenous malformations: how do I embolize?","volume":"10","author":"White","year":"2007","journal-title":"Tech Vasc Interv Radiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1148\/radiol.13122153","article-title":"Treated pulmonary arteriovenous malformations: patterns of persistence and associated retreatment success","volume":"269","author":"Woodward","year":"2013","journal-title":"Radiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5152\/dir.2015.15262","article-title":"Persistence of pulmonary arteriovenous malformations after successful embolotherapy with amplatzer vascular plug: long-term results","volume":"22","author":"Abdel Aal","year":"2016","journal-title":"Diagn Interv Radiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4274\/dir.2024.242732","article-title":"Single-Center 10-year retrospective analysis of amplatzer vascular plug 4 embolization for pulmonary arteriovenous malformations with feeding arteries of <6 mm","volume":"31","author":"Cha","year":"2025","journal-title":"Diagn Interv Radiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jvir.2010.01.026","article-title":"Embolization of pulmonary arteriovenous malformations with amplatzer vascular plugs: safety and midterm effectiveness","volume":"21","author":"Letourneau-Guillon","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.21037\/cdt.2017.12.08","article-title":"Pulmonary arteriovenous malformations: endovascular therapy","volume":"8","author":"Chamarthy","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jtcvs.2017.04.069","article-title":"Surgery versus percutaneous transcatheter embolization for pulmonary arteriovenous malformation: analysis of a national inpatient database in Japan","volume":"154","author":"Nagano","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.crad.2016.12.002","article-title":"Follow-up interval for small untreated pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia","volume":"72","author":"Ryan","year":"2017","journal-title":"Clin Radiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.3390\/jcm14092980","article-title":"Feeding-Artery microvascular plug embolization versus Nidus-plus-feeding-artery coil embolization of pulmonary arteriovenous malformations","volume":"14","author":"Srinivas","year":"2025","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e20220359","DOI":"10.36416\/1806-3756\/e20220359","article-title":"Update on pulmonary arteriovenous malformations","volume":"49","author":"Salibe-Filho","year":"2023","journal-title":"J Bras Pneumol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1002\/ppul.27354","article-title":"Pulmonary arteriovenous malformation in children","volume":"60","author":"Lim","year":"2025","journal-title":"Pediatr Pulmonol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1732994\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:01:46Z","timestamp":1780034506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1732994\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":27,"alternative-id":["10.3389\/fcvm.2026.1732994"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1732994","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1732994"}}